Zealand Pharma — Maj 2024
-
603 så vi igen pre-fredag kursmæssigt
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1165135/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
DevOp ja sådan er det jo med alt i denne branche. At "man lige skal igennem kliniske forsøg"
Jeg ser det som meget sandsynligt der er en betydende positiv impact på muskelvæv. Men præcis hvor meget, og ikke mindst safety profilen, det er det store spørgsmål. AZ smider heller ikke 550 mio kr for et præklinisk stof uden at føle sig meget sikker på den indledende impact -
Mht prisen ved at kombinere flere stoffer. Vi kommer til at se rigtig mange kombi behandlinger. Novo står jo kun ca 18 mdr fra mulig godkendelse af CagriSema som jo er en kombi. Og ja så bliver produktions cost lidt højere. Men det har ingen betyden i denne henseende da bruttomargin allerede er høj
-
Generelt vil vi se amylin stoffer blive kombineret. Og så også stoffer der har positiv impact på muskelmasse
-
Man vil ganske givet også se andre fedme stoffer blive testet som kombi til de patienter der for alvor har høj BMI, og hvor de eksisterende slet ikke kan give stort nok vægttab
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1165660/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Meddelelse: As of 22 May 2024, Polar Capital holds nominally 3,138,798 shares (each share carrying one vote) in Zealand Pharma A/S, corresponding to 5.01% of the total share capital and total voting rights in Zealand Pharma A/S.
-
-
Polar Capital har således øget antallet af af aktier med 3%.
-
Video: Den Europæiske Centralbank ECB sætter formentlig renten ned i næste uge, men hvor meget? Hør også om NVIDIA, Mærsk og DSV's interesse for at købe DB Schenker, samt om de to danske biotekselskaber Zealand Pharma, Novo Nordisk og Genmab. https://proinvestor.com/boards/120672
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1166285/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Kort video....
Pharma- og biotekopdatering uge 22 | Genmab, Zealand Pharma og Novo Nordisk https://proinvestor.com/boards/120686 -
Spændende om det kan øge interessen i USA:
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024 -
Jefferies Global Healthcare Conference, June 4-6 in New York City…….. Goldman Sachs 45th Annual Global Healthcare Conference, June 10-13 in Miami
-
Zealand Pharma: Ekspertpanel anbefaler nødpen udlicenseret til Novo godkendt i EU https://proinvestor.com/investornyt/1166987/zealand-pharma-ekspertpanel-anbefaler-nodpen-udlicenseret-til-novo-godkendt-i-eu
-
Goldman Sachs ser det globale fedmemarked vokse til 130 mia. dollar i 2030 https://proinvestor.com/investornyt/1166978/goldman-sachs-ser-det-globale-fedmemarked-vokse-til-130-mia-dollar-i-2030
-
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
-
Copenhagen, Denmark, May 31, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending granting marketing authorization for dasiglucagon solution for injection in the treatment of severe hypoglycemia in adults, adolescents, and chil
-
"We are very pleased that the European regulatory authorities have recommended approval of dasiglucagon as a rescue treatment for very low blood sugar in people with diabetes," said Adam Steensberg, Chief Executive Officer of Zealand Pharma. "This is an important step in achieving our ambition of bringing this product to many more patients around the world through our partnership with Novo Nordisk, a global leader in diabetes."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind